The glucagon market is expanding as diabetes prevalence rises and drug delivery innovations improve emergency hypoglycemia management worldwide. Market size was estimated at USD 9.007 billion in 2024 and is projected to grow to USD 18.42 billion by 2035, registering a CAGR of 6.72% during 2025-2035. North America leads with approximately 45% global share, with the U.S. as the primary...
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek